Cite
HARVARD Citation
Mocci, G. et al. (2023). Real-world efficacy and safety of vedolizumab in managing ulcerative colitis versus Crohn's disease: results from an Italian multicenter study. Expert opinion on biological therapy. pp. 293-304. [Online].